Impact of galanin receptors 2 and 3 double-knockout on neuroinflammation and functional recovery following traumatic brain injury
Traumatic brain injury (TBI) is one of the world's leading causes of death and disability in young individuals and the mechanism underlying TBI-associated neuroinflammation is poorly understood. The regulatory neuropeptide galanin (GAL) and its three receptors (GAL<sub>1-3</sub>R) are assumed to modulate the neuroinflammatory response following TBI, especially by signalling via GAL<sub>2</sub>R and GAL<sub>3</sub>R. Therefore, the role of GALRs in acute neuroinflammation and functional recovery following moderate Controlled Cortical Impact TBI was studied using GAL<sub>2/3</sub>R-double-KO (GAL<sub>2/3</sub>R-KO) mice. Brains and cerebrospinal fluid (CSF) were collected at day 1 and 30 days post TBI. Functional recovery post TBI was assessed by the modified Neurological Severity Score (mNSS), Elevated Plus Maze (EPM) and Morris Water Maze (MWM) test. Post TBI (day 1-28 post injury), neurological dysfunction was more severe in GAL<sub>2/3</sub>R-KO mice than in WT mice. At 1 day post TBI, inflammatory markers and several nerve growth factors significantly increased in the ipsilateral hemisphere, compared to the contralateral hemisphere in both GAL<sub>2/3</sub>R-KO and WT mice. At 4 days post surgery, TBI mice entered significantly more frequent the open-arms in the EPM compared to Sham-operated mice, suggestive of increased exploratory behaviour in TBI mice. At 30 days post TBI, immunostaining of brain sections revealed significant differences in vascularisation and glial scarring in the cortex when comparing TBI and Sham-operated mice, but genotypes were similar. In summary, the results indicate that GAL<sub>2</sub>R and/or GAL<sub>3</sub>R have a neuroprotective role following moderate TBI, as the severity was significantly lower in their presence than in their absence.
Authors
- Sébastien Couillard‐Després (ORCID: https://orcid.org/0000-0002-8486-6412)
- Sara Huber (ORCID: https://orcid.org/0000-0003-3589-4924)
- Lara Bieler (ORCID: https://orcid.org/0000-0002-1197-0403)
- Barbara Kofler (ORCID: https://orcid.org/0000-0002-1198-4776)
- Felix Sternberg (ORCID: https://orcid.org/0000-0003-3487-362X)
- Stefanie Gaisbauer
- Patrick N. Pallier (ORCID: https://orcid.org/0000-0002-9001-6043)
- Ping K. Yip (ORCID: https://orcid.org/0000-0002-3184-9643)
- Christina Erhardt-Kreutzer
- Theresa Haslauer (ORCID: https://orcid.org/0000-0002-8331-0922)
- Julia Leitner (ORCID: https://orcid.org/0000-0001-7287-2316)
- Susanne M. Brunner (ORCID: https://orcid.org/0000-0002-9623-1115)
- Andrea Ramspacher (ORCID: https://orcid.org/0000-0002-8266-1640)
Institutions
- Queen Mary University of London (GB)
- Paracelsus Medical University (AT)
- Austrian Cluster for Tissue Regeneration (AT)
Publication Details
- Journal
- Peptides
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1016/j.peptides.2025.171415
- Citations
- 1
- Primary Topic
- Traumatic Brain Injury and Neurovascular Disturbances
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Austrian Science Fund
- Österreichische Forschungsförderungsgesellschaft
- Paracelsus Medizinische Privatuniversität